{
    "startDate": "2020-01-01",
    "endDate": "2020-09-30",
    "year": "2020",
    "quarter": "Q3",
    "symbol": "BIIB",
    "data": {
        "bs": [
            {
                "label": "Common stock, par value $0.0005 per share",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000.0
            },
            {
                "label": "Taxes payable",
                "concept": "TaxesPayableCurrent",
                "unit": "usd",
                "value": 119400000.0
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3804000000.0
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 1355000000.0
            },
            {
                "label": "Deferred tax liability",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 1123400000.0
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 5755700000.0
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 5755700000.0
            },
            {
                "label": "Current portion of notes payable",
                "concept": "NotesPayableCurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred tax asset",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": 1372900000.0
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 398400000.0
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 2224800000.0
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 2224800000.0
            },
            {
                "label": "Total Biogen Inc. shareholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 10758500000.0
            },
            {
                "label": "Total liabilities and equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 24934100000.0
            },
            {
                "label": "Total equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 10744500000.0
            },
            {
                "label": "Total equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 10744500000.0
            },
            {
                "label": "Total equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 10744500000.0
            },
            {
                "label": "Preferred stock, par value $0.001 per share",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "biib:DuefromantiCD20therapeuticprograms",
                "unit": "usd",
                "value": 527200000.00000006
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 2024900000.0
            },
            {
                "label": "Notes payable",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 7425000000.0
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 1027700000.0
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1428100000.0
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1428100000.0
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3323600000.0
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3323600000.0
            },
            {
                "label": "Treasury stock, at cost",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 2977100000.0
            },
            {
                "label": "Long-term operating lease liabilities",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 409100000.0
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Retained earnings",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 13961000000.0
            },
            {
                "label": "Investments and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1834900000.0
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
                "unit": "usd",
                "value": 1009800000.0
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -225500000.0
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -225500000.0
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -14000000.0
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 7843100000.0
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3359900000.0
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 24934100000.0
            },
            {
                "label": "Accrued expenses and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 3286200000.0
            },
            {
                "label": "Accrued expenses and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 3286200000.0
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 14189600000.0
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 683500000.0
            },
            {
                "label": "Operating lease assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 434200000.0
            }
        ],
        "cf": [
            {
                "label": "Net distribution to noncontrolling interest",
                "concept": "PaymentsToMinorityShareholders",
                "unit": "usd",
                "value": 70900000.0
            },
            {
                "label": "Net cash flows provided by (used in) investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -442200000.0
            },
            {
                "label": "Depreciation, amortization and impairments",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 366800000.0
            },
            {
                "label": "Share-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 149300000.0
            },
            {
                "label": "Loss on equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 14700000.0
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 270600000.0
            },
            {
                "label": "Acquisitions of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 37000000.0
            },
            {
                "label": "Proceeds from sales of strategic investments",
                "concept": "ProceedsFromSaleOfAvailableForSaleSecuritiesEquity",
                "unit": "usd",
                "value": 500000.0
            },
            {
                "label": "Payments related to issuance of stock for share-based compensation arrangements, net",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 11800000.0
            },
            {
                "label": "Proceeds from borrowings",
                "concept": "ProceedsFromIssuanceOfLongTermDebt",
                "unit": "usd",
                "value": 2967300000.0
            },
            {
                "label": "Loss on divestiture of Hiller\u00f8d, Denmark manufacturing operations",
                "concept": "IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsAttributableToParentBeforeIncomeTax",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -110100000.0
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": -716900000.0
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 22900000.0
            },
            {
                "label": "Unrealized (gain) loss on strategic investments",
                "concept": "IncreaseDecreaseInEquitySecuritiesFvNi",
                "unit": "usd",
                "value": -41800000.0
            },
            {
                "label": "Purchases of treasury stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 6279100000.0
            },
            {
                "label": "Contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 23500000.0
            },
            {
                "label": "Contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 23500000.0
            },
            {
                "label": "Contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 23500000.0
            },
            {
                "label": "Proceeds from divestiture of Hiller\u00f8d, Denmark manufacturing operations",
                "concept": "ProceedsFromSaleOfPropertyPlantAndEquipment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Repayment of borrowings",
                "concept": "RepaymentsOfLongTermDebt",
                "unit": "usd",
                "value": 1500000000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 75000000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 75000000.0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 135700000.0
            },
            {
                "label": "Other changes in operating assets and liabilities, net",
                "concept": "IncreaseDecreaseInOtherOperatingCapitalNet",
                "unit": "usd",
                "value": 97000000.0
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 372900000.0
            },
            {
                "label": "Net cash flows provided by operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 4596900000.0
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 28000000.0
            },
            {
                "label": "Acquisition of Nightstar Therapeutics plc, net of cash acquired",
                "concept": "PaymentsToAcquireBusinessTwoNetOfCashAcquired",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Contingent consideration paid related to Fumapharm AG acquisition",
                "concept": "PaymentsToAcquireOtherProductiveAssets",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "IncreaseDecreaseInDueFromRelatedParties",
                "unit": "usd",
                "value": -63000000.0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 3702900000.0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 3702900000.0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 3702900000.0
            },
            {
                "label": "Proceeds from sales and maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 5240700000.0
            },
            {
                "label": "Proceeds from sales and maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 5240700000.0
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 211900000.0
            },
            {
                "label": "Income tax assets and liabilities",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": 15300000.0
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 4649100000.0
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": 18000000.0
            },
            {
                "label": "Net cash flows used in financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -4871600000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": 75000000.0
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 338800000.0
            }
        ],
        "ic": [
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 23500000.0
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 23500000.0
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 23500000.0
            },
            {
                "label": "Income from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 4880700000.0
            },
            {
                "label": "Cost of sales, excluding amortization and impairment of acquired intangible assets",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 1314600000.0
            },
            {
                "label": "Total cost and expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 5711300000.0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 2264800000.0
            },
            {
                "label": "Total revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 10592000000.0
            },
            {
                "label": "Amortization and impairment of acquired intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 196300000.0
            },
            {
                "label": "Equity in (income) loss of investee, net of tax",
                "concept": "biib:IncomeLossFromEquityMethodInvestmentsNetOfTax",
                "unit": "usd",
                "value": -12700000.0
            },
            {
                "label": "Net\u00a0income (loss) attributable to noncontrolling interests, net\u00a0of\u00a0tax",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 60200000.0
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1698300000.0
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 22.29
            },
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 3642700000.0
            },
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 3642700000.0
            },
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 3642700000.0
            },
            {
                "label": "Other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -186100000.0
            },
            {
                "label": "Other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -186100000.0
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 163400000.0
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 163400000.0
            },
            {
                "label": "Income before income tax expense and equity in loss of investee, net of tax",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 4694600000.0
            },
            {
                "label": "Collaboration profit (loss) sharing",
                "concept": "biib:Collaborationprofitlosssharing",
                "unit": "usd",
                "value": 166500000.0
            },
            {
                "label": "Loss on divestiture of Hiller\u00f8d, Denmark manufacturing operations",
                "concept": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 22.25
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 3702900000.0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 3702900000.0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 3702900000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 75000000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 75000000.0
            },
            {
                "label": "Income tax expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 979000000.0
            },
            {
                "label": "Restructuring charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 163700000.0
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 163700000.0
            },
            {
                "label": "Unrealized gains (losses) on pension benefit obligation, net of tax",
                "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "unit": "usd",
                "value": -400000.0
            },
            {
                "label": "Total other comprehensive income (loss), net of tax",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": -90300000.0
            },
            {
                "label": "Total other comprehensive income (loss), net of tax",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": -90300000.0
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 61100000.0
            },
            {
                "label": "Comprehensive income attributable to Biogen Inc.",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 3613500000.0
            },
            {
                "label": "Gains (losses) on net investment hedges",
                "concept": "TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 5500000.0
            },
            {
                "label": "Unrealized gains (losses) on cash flow hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
                "unit": "usd",
                "value": -101100000.0
            },
            {
                "label": "Unrealized gains (losses) on securities available for sale, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": 1000000.0
            },
            {
                "label": "Comprehensive income",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 3552400000.0
            },
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 3642700000.0
            },
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 3642700000.0
            },
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 3642700000.0
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 3900000.0
            }
        ]
    }
}